These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 16825867)

  • 21. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions.
    Lee CW; Matulonis UA; Castells MC
    Gynecol Oncol; 2004 Nov; 95(2):370-6. PubMed ID: 15491759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer.
    Nozawa H; Muto Y; Yamada Y
    Clin Ther; 2008 Jun; 30(6):1160-5. PubMed ID: 18640472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.
    Hesterberg PE; Banerji A; Oren E; Penson RT; Krasner CN; Seiden MV; Wong JT
    J Allergy Clin Immunol; 2009 Jun; 123(6):1262-7.e1. PubMed ID: 19501233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of hypersensitivity reactions to antineoplastic agents.
    Cortijo-Cascajares S; Jiménez-Cerezo MJ; Herreros de Tejada A
    Farm Hosp; 2012; 36(3):148-58. PubMed ID: 22484106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents.
    Lee C; Gianos M; Klaustermeyer WB
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):179-87; quiz 187-9, 222. PubMed ID: 19354063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid desensitization for hypersensitivity reactions to medications.
    Castells M
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):585-606. PubMed ID: 19563999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypersensitivity reactions to docetaxel: retrospective evaluation and development of a desensitization protocol.
    Syrigou E; Dannos I; Kotteas E; Makrilia N; Tourkantonis I; Dilana K; Gkiozos I; Saif MW; Syrigos KN
    Int Arch Allergy Immunol; 2011; 156(3):320-4. PubMed ID: 21720178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxaliplatin hypersensitivity: case report and successful repeat desensitization.
    Edmondson DA; Gruling BJ; Urmanski AM; Wong SJ; Levy MB
    Am J Ther; 2007; 14(1):116-8. PubMed ID: 17303980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypersensitivity reactions to anticancer chemotherapy and monoclonal antibodies: Safety and efficacy of desensitization.
    Villarreal-González RV; González-Díaz S; Vidal-Gutiérrez O; Cruz-de la Cruz C; Pérez-Ibave DC; Garza-Rodríguez ML
    J Oncol Pharm Pract; 2024 Jul; 30(5):811-822. PubMed ID: 37489025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review.
    Picard M; Castells MC
    Clin Rev Allergy Immunol; 2015 Oct; 49(2):177-91. PubMed ID: 24740483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization.
    Castells M; Sancho-Serra Mdel C; Simarro M
    Cancer Immunol Immunother; 2012 Sep; 61(9):1575-84. PubMed ID: 22576054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies.
    Hong DI; Bankova L; Cahill KN; Kyin T; Castells MC
    Expert Rev Clin Immunol; 2012 Jan; 8(1):43-52; quiz 53-4. PubMed ID: 22149339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid desensitization protocols for patients with cardiovascular disease and aspirin hypersensitivity in an era of dual antiplatelet therapy.
    Page NA; Schroeder WS
    Ann Pharmacother; 2007 Jan; 41(1):61-7. PubMed ID: 17200429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies.
    Sloane D; Govindarajulu U; Harrow-Mortelliti J; Barry W; Hsu FI; Hong D; Laidlaw T; Palis R; Legere H; Bunyavanich S; Breslow R; Wesemann D; Barrett N; Brennan P; Chong HJ; Liu A; Fernandez J; Fanning L; Kyin T; Cahill K; Bankova L; Lynch A; Berlin S; Campos S; Fuchs C; Mayer R; Matulonis U; Castells M
    J Allergy Clin Immunol Pract; 2016; 4(3):497-504. PubMed ID: 26895621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. General considerations on rapid desensitization for drug hypersensitivity - a consensus statement.
    Cernadas JR; Brockow K; Romano A; Aberer W; Torres MJ; Bircher A; Campi P; Sanz ML; Castells M; Demoly P; Pichler WJ;
    Allergy; 2010 Nov; 65(11):1357-66. PubMed ID: 20716314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypersensitivity reactions to oxaliplatin: what nurses need to know.
    Bonosky K; Miller R
    Clin J Oncol Nurs; 2005 Jun; 9(3):325-30. PubMed ID: 15973843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypersensitivity Reactions to Oxaliplatin: Identifying the Risk Factors and Judging the Efficacy of a Desensitization Protocol.
    Okayama T; Ishikawa T; Sugatani K; Yoshida N; Kokura S; Matsuda K; Tsukamoto S; Ihara N; Kuriu Y; Nakanishi M; Nakamura T; Kamada K; Katada K; Uchiyama K; Takagi T; Handa O; Konishi H; Yagi N; Naito Y; Otsuji E; Hosoi H; Miki T; Itoh Y
    Clin Ther; 2015 Jun; 37(6):1259-69. PubMed ID: 25862137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful desensitization to oxaliplatin.
    Mis L; Fernando NH; Hurwitz HI; Morse MA
    Ann Pharmacother; 2005 May; 39(5):966-9. PubMed ID: 15784807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy.
    Wang AL; Patil SU; Long AA; Banerji A
    Ann Allergy Asthma Immunol; 2015 Nov; 115(5):422-8. PubMed ID: 26298407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol.
    Syrigou EI; Karapanagiotou EM; Alamara CV; Boura PG; Saif MW; Syrigos KN
    Clin Colorectal Cancer; 2009 Apr; 8(2):106-9. PubMed ID: 19739272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.